Virus para contrarrestar otros virus: el uso de vacunas vectorizadas, lo que viene
References
Palomares, Laura. elcolegionacionalmx. (8 de mayo de 2020). ¿Vale la pena investigar y desarrollar vacunas en México? [Archivo de video]. Youtube. https://youtu.be/SBlaczqL16o
Callaway, E. (28 de abril de 2020). The race for coronavirus vaccines: a graphical guide. Nature, Recuperado el 04 de octubre de 2020 de http://doi.org/10.1038/d41586-020-01221-y
Folgori, A., & Capone, S. (2012). Engineered viruses as vaccine platforms. In Innovation in Vaccinology (pp. 65-86). Springer, Dordrecht.
Kim, S. H., & Samal, S. K. (2016). Newcastle disease virus as a vaccine vector for development of human and veterinary vaccines. Viruses, 8(7), 183.
Ura, T., Okuda, K., & Shimada, M. (2014). Developments in viral vector-based vaccines. Vaccines, 2(3), 624-641.
Jorge, S., & Dellagostin, O. A. (2017). The development of veterinary vaccines: a review of traditional methods and modern biotechnology approaches. Biotechnology Research and Innovation, 1(1), 6-13.
Tlaxca, J. L., Ellis, S., & Remmele Jr, R. L. (2015). Live attenuated and inactivated viral vaccine formulation and nasal delivery: Potential and challenges. Advanced drug delivery reviews, 93, 56-78
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista de divulgación científica iBIO
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Self-archiving or deposit of the works in their post-publication version (editorial version) is permitted in any personal, institutional or thematic repository, social or scientific networks. The above applies from the moment of publication of the article in question on the website of the Revista de divulgación científica iBIO.
